LINC02101

Across TCGA pan-cancer cohorts, LINC02101 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02101 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02101 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02101 expression acts as an unfavorable survival marker, although some lineages such as PAAD and BRCA show a favorable association.

BLCA, PAAD, and LUSC are the cancer types where LINC02101 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	II,III,IV	0.295	0.500	.004	51	view →
PAAD	DFS	Tertile	All	0.625	0.228	<.001	42	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	37	view →
BRCA	DFS	Median	III,IV	0.867	0.720	.002	16	view →
KIRP	DFS	Quartile	All	0.762	0.887	.009	15	view →
TGCT	DFS	Tertile	II,III,IV	0.678	0.996	.012	12	view →
READ	OS	Tertile	III,IV	0.565	0.925	<.001	12	view →
KICH	DFS	Tertile	III,IV	0.369	0.804	.035	12	view →
LUAD	DFS	Tertile	IV	0.273	0.710	.027	12	view →
THYM	OS	Tertile	All	0.861	0.982	.022	9	view →
GBM	OS	Quartile	All	0.337	0.446	.031	6	view →
ESCA	DFS	Median	All	0.471	0.297	.017	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02101–BLCA (OS)

Open the BLCA breakdown →